We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: GLP-1 weight-loss medication pose hidden dangers for younger ladies, warn consultants
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > GLP-1 weight-loss medication pose hidden dangers for younger ladies, warn consultants
GLP-1 weight-loss medication pose hidden dangers for younger ladies, warn consultants
Health

GLP-1 weight-loss medication pose hidden dangers for younger ladies, warn consultants

Last updated: September 9, 2025 8:48 am
Editorial Board Published September 9, 2025
Share
SHARE

Credit score: Unsplash/CC0 Public Area

Girls taking standard weight-loss medicines throughout their reproductive years could also be unaware of related dangers to being pregnant and unborn infants, warn Flinders College researchers.

A brand new examine has revealed that almost all Australian ladies of reproductive age prescribed GLP-1 receptor agonists—medicines more and more used for weight reduction comparable to Ozempic—will not be utilizing efficient contraception, regardless of recognized dangers throughout being pregnant.

Printed within the Medical Journal of Australia, the analysis analyzed information from over 1.6 million ladies aged 18 to 49 who attended common practices between 2011 and 2022. Of the 18,010 ladies who have been first prescribed GLP-1 receptor agonists throughout that point, solely 21% had reported utilizing contraception.

The paper is titled “Incidence of GLP-1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011–2022: a retrospective open cohort study.”

Initially developed to handle sort 2 diabetes, GLP-1 receptor agonists have gained recognition for his or her appetite-suppressing and weight-loss results, with the examine discovering that almost all prescriptions at the moment are issued to ladies with out diabetes.

Lead writer and pharmacist, Affiliate Professor Luke Grzeskowiak, says that in 2022 alone, greater than 6,000 ladies started remedy on GLP-1s, and over 90% of these didn’t have a diabetes prognosis.

“We’re seeing widespread use of these medications among women of childbearing age, but very little evidence that contraception is being considered as part of routine care,” says Affiliate Professor Grzeskowiak from the School of Drugs and Public Well being.

“These medications can be incredibly helpful, but they’re not risk-free, especially during pregnancy.”

The examine discovered that 2.2% of girls grew to become pregnant inside six months of beginning GLP-1 remedy with being pregnant charges highest amongst youthful ladies with diabetes, and amongst ladies with out diabetes of their early thirties.

Girls with polycystic ovary syndrome have been twice as prone to conceive, suggesting that weight reduction might enhance fertility, even when unintended.

Importantly, ladies who have been utilizing contraception on the time of prescribing had a considerably decrease threat of being pregnant.

A earlier overview of animal research from the College of Amsterdam linked GLP-1 publicity throughout being pregnant to lowered fetal development and skeletal abnormalities, and whereas human information are restricted, the potential dangers stay regarding.

“While the UK advises that women using GLP-1 receptor agonists should avoid pregnancy and use effective contraception, this advice is not being followed consistently in Australian clinical practice,” says Affiliate Professor Grzeskowiak.

“We have to make sure that reproductive well being is a part of each dialog when these medication are prescribed to any ladies of childbearing age.

“It’s also vitally necessary that now we have clearer apply suggestions and tips for these prescribing GLP-1s to ladies to make sure their secure and efficient use.

“Our advice is to speak to your GP about the risks and benefits of GLP-1 medicines before taking them, and only take those prescribed by a health care professional.”

The authors say that additional research evaluating the impression of those medicines on being pregnant and unborn infants are warranted.

Extra data:
Kailash Thapaliya et al, Incidence of GLP‐1 receptor agonist use by ladies of reproductive age attending common practices in Australia, 2011–2022: a retrospective open cohort examine, Medical Journal of Australia (2025). DOI: 10.5694/mja2.70026

Offered by
Flinders College

Quotation:
GLP-1 weight-loss medication pose hidden dangers for younger ladies, warn consultants (2025, September 9)
retrieved 9 September 2025
from https://medicalxpress.com/information/2025-09-glp-weight-loss-drugs-pose.html

This doc is topic to copyright. Aside from any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

Psilocybin may reverse results of mind accidents ensuing from intimate associate violence, rat research finds

Predicting illness outbreaks utilizing social media

Deep mind stimulation succeeds for 1 in 2 sufferers with treatment-resistant extreme melancholy and nervousness in trial

Australian drug driving deaths have surpassed drunk driving. Here is the way to deal with it

Tooth of infants of confused moms come out earlier, suggests examine

TAGGED:drugsExpertsGLP1hiddenposeRiskswarnWeightlossWomenyoung
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Incident gabapentin use not linked to extend in falls vs. duloxetine
Health

Incident gabapentin use not linked to extend in falls vs. duloxetine

Editorial Board January 7, 2025
U.S. Retakes Top Spot in Supercomputer Race
Andrea Chung’s Afrofuturism of Cyanotypes and Sugar
Beach Houses on the Outer Banks Are Being Swallowed by the Sea
Celtics’ Horford Turns Back the Clock and the Bucks

You Might Also Like

New malaria drug heralds resistance breakthrough
Health

New malaria drug heralds resistance breakthrough

November 18, 2025
Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain
Health

Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain

November 18, 2025
The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years
Health

The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years

November 18, 2025
Breast most cancers remedies can enhance each survival probabilities and revenue
Health

Breast most cancers remedies can enhance each survival probabilities and revenue

November 18, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?